Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Types of Research Grants


Grants Overview Types of Grants Process and Timeline Funded Studies

The Alzheimer's Association funds a wide variety of investigations by scientists at every stage of their careers. Each grant is designed to meet the needs of the field and to introduce fresh ideas in Alzheimer's research.




NEW: 2017 June Part the Cloud Translational (PTC) Research for Alzheimer’s Disease Program (March - August 2017)


In its sixth iteration, the Alzheimer's Association is pleased to announce the Part the Cloud Translational Research Funding initiative to increase the research efforts in Phase I and Phase II (Proof of Concept) clinical trials directed towards Alzheimer’s disease and related dementias internationally. This new grant mechanism aims to fill the gap in Alzheimer’s disease drug development by providing support for early phase studies of potential Alzheimer’s therapeutics or validation of biological markers of disease progression.

Applications will be accepted from academic investigators and small companies with lead candidate therapeutic agents that require early stage testing prior to Proof of Concept (POC) Phase 2 or 3 efficacy studies, or with lead therapeutic agents that have already established human safety data and require a small-scale pilot Proof of Mechanism (POM) study to begin proving the scientific concept in humans. This award will support Phase 1 studies or pilot small-scale Phase 2a studies for repurposed drugs in normal individuals or individuals with preclinical or symptomatic Alzheimer’s disease (i.e. early human studies to set the stage for efficacy studies), including single and multiple dose studies to establish safety, brain penetration and/or target engagement and POM in preparation for larger proof of concept trials. In addition, proposals may be considered that are POC to validate biological marker(s) of disease progression in a clinical trial environment. Any proposal must have a clear focus on Alzheimer’s disease and related disorder and be translational in nature. All proposals should clearly and explicitly outline the measure to be investigated, the methods for study, and outcomes. Researchers from underrepresented groups are encouraged to apply.

Eligibility: Both non-profit and small for-profit agencies are eligible. Open to International Applicants. Small for-profit agencies must submit documentation of net assets and annual earnings during the letter of intent process as a part of the review process. Not-for-profit organizations must submit documentation verifying status during the letter of intent process.

CLOSED: 2017 International Research Grant Program - June Program (February 2017 - August 2017)


CLOSED: Alzheimer’s Association Research Grant (AARG)

The Alzheimer’s Association Research Grant aims to fund investigators who are less than 10 years past their doctoral or post residency (MD or DO) or investigators that are new to Alzheimer’s and related dementia field of research even if past the 10yrs. Individuals who are new to the field of Neuroscience/Alzheimer’s will need to contact the Association at grantsapp@alz.org to receive exception prior to submitting an LOI. The purpose of this program is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to the National Institutes of Health, National Science Foundation and other funding agencies and groups, including future proposals to the Alzheimer's Association. This program is a three year (minimum 2 year) award.


CLOSED: Alzheimer’s Association Research Grant to Promote Diversity (AARG-D)

The Alzheimer’s Association Research Grant to Promote Diversity program is a three year (minimum 2 year) award to increase the number of scientist from underrepresented groups at academic institutions in Alzheimer’s or related dementias research. The AARG-D aims to fund investigators who are less than 10 years past their doctoral or post residency (MD or DO) or investigators that are new to Alzheimer’s and related dementia field of research even if past the 10yrs. Individuals who are new to the field of Neuroscience/Alzheimer’s will need to contact the Association at grantsapp@alz.org to receive exception prior to submitting an LOI.


CLOSED: Alzheimer’s Association Research Fellowship (AARF)

The Alzheimer’s Association Research Fellowship Award Program is a three year (minimum 2 year) award intended to support exceptional researchers who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) with the goal of bridging the fellow to faculty positions of researchers.


CLOSED: Alzheimer’s Association Research Fellowship to Promote Diversity (AARF-D)

The Alzheimer’s Association Research Fellowship Award to Promote Diversity Program is a three year (minimum 2 year) award intended to support exceptional researchers who are currently underrepresented at academic institutions in Alzheimer’s or related dementias research and who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) with the goal of bridging fellow to faculty position of researchers.


CLOSED: Alzheimer’s Association Clinician Scientist Fellowship (AACSF)

The Alzheimer’s Association Clinician Scientist Fellowship is a three year (minimum 2 year) award. The Alzheimer's Association recognizes the need to support the training of clinician scientists in Alzheimer's and related dementias. For the purpose of this program, a clinician scientist is defined as an individual already trained, licensed and practicing in a clinical field that includes patient contact (e.g., neurology, psychiatry, geriatrics, psychology) or patient-related diagnostic studies (e.g., neuropathology and radiology). Applicants who hold an M.D. or D.O. degree or applicants with a Ph.D. who have licensure for clinical practice are eligible. The areas of research that the clinician scientist proposes for funding are not limited to patient-oriented, human subject research, but may also include translational research specifically designed to develop treatments or enhance diagnosis of neurological disease.

Please note individuals must be currently in a clinical setting.


CLOSED: Alzheimer’s Association Clinician Scientist Fellowship to Promote Diversity (AACSF-D)

The Alzheimer’s Association Clinician Scientist Fellowship to Promote Diversity is up to three years (minimum 2 years) and is intended to support exceptional clinician scientist who are currently underrepresented at academic institutions in clinical research training in Alzheimer's and related dementias. Applicants who hold an M.D. or D.O. degree or applicants with a Ph.D. who have licensure for clinical practice are eligible. For the purpose of this fellowship, clinical research is defined as patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases. The Alzheimer’s Association recognizes the need to increase the number of underrepresented clinicians participating in clinical research. The Association anticipates that by providing this funding opportunity, the number of underrepresented physicians entering and remaining in clinical careers in Alzheimer’s disease will increase.

Please note individuals must be currently in a clinical setting.


CLOSED: The Zenith Fellows Award Program (Zenith)

The Zenith Fellows award was initiated in 1991 to provide a vehicle for research support for donors with a substantial personal commitment to the advancement of Alzheimer’s disease research. The awards are made possible by the generosity of a group of individuals and organizations (Zenith Society) that have each committed $1 million to the Alzheimer‘s Association for support of the program.

The objective of the 2017 Zenith Fellows Awards competition is to provide major support for investigators who have:

  • Contributed significantly to the field of Alzheimer's disease research
  • Made significant contributions to other areas of science and are now beginning to focus more directly on problems related to Alzheimer's disease, and 
  • Are likely to make substantial contributions in the future.

The proposed research must be "on the cutting edge" of basic science or biomedical research and thus may not conform to current conventional scientific wisdom or may challenge the prevailing orthodoxy. The proposed research should address fundamental problems related to early detection, etiology, pathogenesis, treatment and/or prevention of Alzheimer's disease.   

CLOSED: 2017 International Research Grant Program - January Program
(August 2016 - January 2017)

 


 

 

 

For more information: Contact grantsapp@alz.org or call 312.335.5747.